HUT54660A - Process for producing new cyclic anthranilic acid-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient - Google Patents
Process for producing new cyclic anthranilic acid-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds as active ingredientInfo
- Publication number
- HUT54660A HUT54660A HU903887A HU388790A HUT54660A HU T54660 A HUT54660 A HU T54660A HU 903887 A HU903887 A HU 903887A HU 388790 A HU388790 A HU 388790A HU T54660 A HUT54660 A HU T54660A
- Authority
- HU
- Hungary
- Prior art keywords
- compounds
- active ingredient
- pharmaceutical compositions
- carboxylic acid
- producing new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15657889 | 1989-06-19 |
Publications (3)
Publication Number | Publication Date |
---|---|
HU903887D0 HU903887D0 (en) | 1990-11-28 |
HUT54660A true HUT54660A (en) | 1991-03-28 |
HU209294B HU209294B (en) | 1994-04-28 |
Family
ID=15630828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU903887A HU209294B (en) | 1989-06-19 | 1990-06-18 | Process for producing new cyclic anthranilic acid-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient |
Country Status (8)
Country | Link |
---|---|
US (1) | US5112836A (hu) |
EP (1) | EP0403980A1 (hu) |
JP (1) | JPH0386866A (hu) |
KR (1) | KR960007086B1 (hu) |
CN (1) | CN1048216A (hu) |
AU (1) | AU624963B2 (hu) |
CA (1) | CA2019200A1 (hu) |
HU (1) | HU209294B (hu) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2996845A1 (fr) * | 2012-10-12 | 2014-04-18 | Servier Lab | Nouveau procede de synthese du 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH139412A (de) * | 1927-11-19 | 1930-04-15 | Chem Ind Basel | Verfahren zur Darstellung eines einseitig heterocyklisch acylierten Diamins. |
US4956372A (en) * | 1987-10-02 | 1990-09-11 | Kyorin Pharmaceutical Co., Ltd. | Cyclic anthranilic acid derivatives and process for their preparation |
-
1990
- 1990-06-15 EP EP90111353A patent/EP0403980A1/en not_active Withdrawn
- 1990-06-15 US US07/538,785 patent/US5112836A/en not_active Expired - Fee Related
- 1990-06-18 KR KR1019900008920A patent/KR960007086B1/ko not_active IP Right Cessation
- 1990-06-18 AU AU57703/90A patent/AU624963B2/en not_active Ceased
- 1990-06-18 JP JP2159521A patent/JPH0386866A/ja active Pending
- 1990-06-18 HU HU903887A patent/HU209294B/hu not_active IP Right Cessation
- 1990-06-18 CA CA002019200A patent/CA2019200A1/en not_active Abandoned
- 1990-06-19 CN CN90103055A patent/CN1048216A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
KR910000651A (ko) | 1991-01-29 |
AU5770390A (en) | 1990-12-20 |
AU624963B2 (en) | 1992-06-25 |
JPH0386866A (ja) | 1991-04-11 |
US5112836A (en) | 1992-05-12 |
CA2019200A1 (en) | 1990-12-19 |
HU903887D0 (en) | 1990-11-28 |
CN1048216A (zh) | 1991-01-02 |
HU209294B (en) | 1994-04-28 |
EP0403980A1 (en) | 1990-12-27 |
KR960007086B1 (ko) | 1996-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT64065A (en) | Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT51254A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT61989A (en) | Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient | |
HUT49629A (en) | Process for producing peptide-boronic acid derivatives inhibiting trypsin-like proteases and pharmaceutical compositions comprising such compounds as active ingredient | |
HU900118D0 (en) | Process for preparation of new cyclic amine-derivatives and for manufacturing of pharmaceutical compositions containing these compounds as active ingredient | |
HUT56270A (en) | Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT47131A (en) | Process for producing steroid-5alpha-reductase inhibitors and pharmaceutical compositions comprising them as active ingredient | |
HUT58060A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT61751A (en) | Process for producing benzofuran derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT60466A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT59106A (en) | Process for producing 3-amidopyrazoles and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT46654A (en) | Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient | |
HUT63163A (en) | Process for producing anxiety relieving bis-azabicyclo compounds and pharmaceutical compositions comprising same as active ingredient | |
HUT48609A (en) | Process for producing kumaran derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT55403A (en) | Process for producing modified gangliosides and their functional derivatives, as well as pharmaceutical compositions comprising such active ingredient | |
HUT64013A (en) | Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT47123A (en) | Process for producing phosphorous compounds and pharmaceutical compositions comprising them as active ingredient, as well as their intermediates | |
HUT53897A (en) | Process for producing benzopyran derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT54671A (en) | Process for producing benzothiopirane derivatives and pharmaceutical compositions containing them as active component | |
HUT50112A (en) | Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component | |
HUT50334A (en) | Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient | |
HUT49598A (en) | Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT59116A (en) | Process for producing oxazole derivatives and pharmaceutical compositions comprising oxazole derivatives as active ingredient | |
HUT58082A (en) | Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT50789A (en) | Process for producing renin inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HMM4 | Cancellation of final prot. due to non-payment of fee |